TrialA Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
Trial details
- Registry ID
- NCT05387083
- Phase
- Phase 2
Drug research
High Dose TP-05
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Lotilaner
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05NCT05387083 | TARS | Phase 2 | Completed | 2024-06-26Actual |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |